Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.30 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.30 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21099046 | 0.89 | DHODH (0.34) | BRD4HIF1AKAT6APDK2MAPK14 | |
| SCHEMBL22650171 | 0.86 | KDM4E (0.36) | HIF1AKAT6AKDM4ENPC1ALDH1A1 | |
| SCHEMBL22147418 | 0.83 | CNR1 (0.37) | SIRT2SCN9AKAT6ASCN5AKDM4E | |
| SCHEMBL22085115 | 0.82 | MAPK1 (0.38) | MAPK14ADORA3KDM4ENPC1ALDH1A1 | |
| SCHEMBL21098931 | 0.82 | SMN1; SMN2 (0.41) | SIRT2HIF1AKDM4ENPC1ALDH1A1 | |
| SCHEMBL20169564 | 0.80 | KDM4E (0.37) | KDM4ENPC1ALDH1A1SMN1; SMN2 | |
| SCHEMBL20169567 | 0.79 | KAT6A (0.35) | SCN9AHIF1AKAT6AKDM4ETP53 | |
| SCHEMBL23921477 | 0.79 | CCR1 (0.34) | — | |
| SCHEMBL20195362 | 0.78 | SMN1; SMN2 (0.41) | SIRT2SCN9AHIF1ASCN5AKDM4E | |
| SCHEMBL23193559 | 0.77 | SERPINE1 (0.32) | KDM4EALDH1A1TP53MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10323006-B2 | Heterocyclic compound and organic light emitting element using same | LG CHEM, LTD. (KR) | 2019-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10323006-B2 | Heterocyclic compound and organic light emitting element using same | CRY1, CRY2, NR2E3 | SIRT2 1186/4885BRD4 452/4885SCN9A 3091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.